AAAAAA
Results:
1-22
|
Results: 22
Authors:
Oerther, S
Ahlenius, S
Citation: S. Oerther et S. Ahlenius, Involvement of 5-HT1A and 5-HT1B receptors for citalopram-induced hypothermia in the rat, PSYCHOPHAR, 154(4), 2001, pp. 429-434
Authors:
Ahlenius, S
Ericson, E
Citation: S. Ahlenius et E. Ericson, Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats, J NEURAL TR, 108(4), 2001, pp. 415-430
Authors:
Eltayb, A
Svensson, TH
Ahlenius, S
Citation: A. Eltayb et al., Catalepsy induced by the 5-HT1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram, EUR J PHARM, 411(3), 2001, pp. 275-277
Authors:
Eltayb, A
Lindblom, S
Oerther, S
Ahlenius, S
Citation: A. Eltayb et al., Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D-2/3 receptor agonist 7-OH-DPAT in the rat, ACT PHYSL S, 172(3), 2001, pp. 205-209
Authors:
Arborelius, L
Linner, L
Wallsten, C
Ahlenius, S
Svensson, TH
Citation: L. Arborelius et al., Partial 5-HT1A receptor agonist properties of (-)pindolol in combination with citalopram on serotonergic dorsal raphe cell firing in vivo, PSYCHOPHAR, 151(1), 2000, pp. 77-84
Authors:
Salmi, P
Ahlenius, S
Citation: P. Salmi et S. Ahlenius, Sedative effects of the dopamine D-1 receptor agonist A 68930 on rat open-field behavior, NEUROREPORT, 11(6), 2000, pp. 1269-1272
Authors:
Kaur, P
Ahlenius, S
Citation: P. Kaur et S. Ahlenius, Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?, J NEURAL TR, 107(8-9), 2000, pp. 903-917
Authors:
Wadenberg, ML
Hertel, P
Fernholm, R
Blakeman, KH
Ahlenius, S
Svensson, TH
Citation: Ml. Wadenberg et al., Enhancement of antipsychotic-like effects by combined treatment with the alpha(1)-adrenoceptor antagonist prazosin and the dopamine D-2 receptor antagonist raclopride in rats, J NEURAL TR, 107(10), 2000, pp. 1229-1238
Authors:
Eriksson, C
Zou, LP
Ahlenius, S
Winblad, B
Schultzberg, M
Citation: C. Eriksson et al., Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists, MOL BRAIN R, 85(1-2), 2000, pp. 103-113
Authors:
Uvnas-Moberg, K
Eklund, M
Hillegaart, V
Ahlenius, S
Citation: K. Uvnas-moberg et al., Improved conditioned avoidance learning by oxytocin administration in high-emotional male Sprague-Dawley rats, REGUL PEPT, 88(1-3), 2000, pp. 27-32
Authors:
Vasquez, PAJ
Salmi, P
Ahlenius, S
Mathe, AA
Citation: Paj. Vasquez et al., Neuropeptide Y in brains of the Flinders Sensitive Line rat, a model of depression. Effects of electroconvulsive stimuli and d-amphetamine on peptideconcentrations and locomotion, BEH BRA RES, 111(1-2), 2000, pp. 115-123
Authors:
Hillegaart, V
Magnusson, O
Ahlenius, S
Citation: V. Hillegaart et al., A9 and A10 dopamine nuclei as a site of action for effects of 8-OH-DPAT onlocomotion in the rat, PHARM BIO B, 67(1), 2000, pp. 55-63
Authors:
Oerther, S
Ahlenius, S
Citation: S. Oerther et S. Ahlenius, Atypical antipsychotics and dopamine D-1 receptor agonism: An in vivo experimental study using core temperature measurements in the rat, J PHARM EXP, 292(2), 2000, pp. 731-736
Authors:
Ahlenius, S
Ericson, E
Florvall, L
Jimenez, P
Hillegaart, V
Wijkstrom, A
Citation: S. Ahlenius et al., In vivo characterization of novel full and partial 2-(4-aminophenyl)-N,N-dipropylethylamine dopamine D-2 receptor agonists, EUR J PHARM, 394(2-3), 2000, pp. 247-253
Authors:
Uvnas-Moberg, K
Bjorkstrand, E
Hillegaart, V
Ahlenius, S
Citation: K. Uvnas-moberg et al., Oxytocin as a possible mediator of SSRI-induced antidepressant effects, PSYCHOPHAR, 142(1), 1999, pp. 95-101
Authors:
Ahlenius, S
Henriksson, I
Magnusson, O
Salmi, P
Citation: S. Ahlenius et al., In vivo intrinsic efficacy of the 5-HT1A receptor antagonists NAD-299, WAY-100,635 and (S)-(-)-UH-301 at rat brain monoamine receptors, EUR NEUROPS, 9(1-2), 1999, pp. 15-19
Authors:
Ahlenius, S
Citation: S. Ahlenius, Clozapine: Dopamine D-1 receptor agonism in the prefrontal cortex as the code to decipher a rosetta stone of antipsychotic drugs, PHARM TOX, 84(5), 1999, pp. 193-196
Authors:
Uvnas-Moberg, K
Bjorkstrand, E
Salmi, P
Johansson, C
Astrand, M
Ahlenius, S
Citation: K. Uvnas-moberg et al., Endocrine and behavioral traits in low-avoidance Sprague-Dawley rats, REGUL PEPT, 80(1-2), 1999, pp. 75-82
Authors:
Arborelius, L
Wallsten, C
Ahlenius, S
Svensson, TH
Citation: L. Arborelius et al., The 5-HT1A receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing, EUR J PHARM, 382(2), 1999, pp. 133-138
Authors:
Ahlenius, S
Larsson, K
Citation: S. Ahlenius et K. Larsson, Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior, EUR J PHARM, 379(1), 1999, pp. 1-6
Authors:
Ericson, E
Ahlenius, S
Citation: E. Ericson et S. Ahlenius, Suggestive evidence for inhibitory effects of galanin on mesolimbic dopaminergic neurotransmission, BRAIN RES, 822(1-2), 1999, pp. 200-209
Authors:
Hillegaart, V
Ahlenius, S
Citation: V. Hillegaart et S. Ahlenius, Facilitation and inhibition of male rat ejaculatory behaviour by the respective 5-HT1A and 5-HT1B receptor agonists 8-OH-DPAT and anpirtoline, as evidenced by use of the corresponding new and selective receptor antagonists NAD-299 and NAS-181, BR J PHARM, 125(8), 1998, pp. 1733-1743
Risultati:
1-22
|